Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels (2022)
- Authors:
- USP affiliated authors: BORTOLANZA, MARIZA - FMRP ; PINHEIRO, LUCAS CÉZAR - EERP ; CARNIO, EVELIN CAPELLARI - EERP ; GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; TUMAS, VITOR - FMRP ; PIMENTEL, ANGELA VIEIRA - FMRP
- Unidades: FMRP; EERP; FORP
- DOI: 10.1007/s00702-021-02447-4
- Subjects: DOENÇA DE PARKINSON; METABOLISMO; ÓXIDO NÍTRICO; DISCINESIAS; LÍQUIDO CEFALORRAQUIDIANO
- Keywords: Nitric oxide; Parkinson’s disease; Dyskinesia; Levodopa
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Neural Transmission
- ISSN: 0300-9564
- Volume/Número/Paginação/Ano: v. 129, n. 1, p. 55-63, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: cc-by-nc-nd
-
ABNT
SANTOS-LOBATO, Bruno Lopes et al. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels. Journal of Neural Transmission, v. 129, n. 1, p. 55-63, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00702-021-02447-4. Acesso em: 01 jan. 2026. -
APA
Santos-Lobato, B. L., Bortolanza, M., Pinheiro, L. C., Batalhão, M. E., Pimentel, A. V., Cárnio, E. C., et al. (2022). Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels. Journal of Neural Transmission, 129( 1), 55-63. doi:10.1007/s00702-021-02447-4 -
NLM
Santos-Lobato BL, Bortolanza M, Pinheiro LC, Batalhão ME, Pimentel AV, Cárnio EC, Del Bel EA, Tumas V. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels [Internet]. Journal of Neural Transmission. 2022 ; 129( 1): 55-63.[citado 2026 jan. 01 ] Available from: https://doi.org/10.1007/s00702-021-02447-4 -
Vancouver
Santos-Lobato BL, Bortolanza M, Pinheiro LC, Batalhão ME, Pimentel AV, Cárnio EC, Del Bel EA, Tumas V. Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels [Internet]. Journal of Neural Transmission. 2022 ; 129( 1): 55-63.[citado 2026 jan. 01 ] Available from: https://doi.org/10.1007/s00702-021-02447-4 - Metabolic profile in plasma and CSF of LEVODOPA-induced dyskinesia in Parkinson’s disease: focus on neuroinflammation
- Interferon-γ involvement in the neuroinflammation associated with Parkinson’s disease and L-DOPA-induced dyskinesia
- Cytoarchitecture of nitrergic neurons in the human striatum and subthalamic nucleus
- Effects of aging on nitrergic neurons in human striatum and subthalamic nucleus
- Doença de parkinson: interação entre os sistemas dopaminérgico e nitrégico na discinesia induzida pelo tratamento crônico com L-DOPA
- Repurposing an established drug: an emerging role for methylene blue in L‐DOPA‐induced dyskinesia
- Nitric oxide, a new player in l-dopa-induced dyskinesia?
- Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats
- Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats
- A percepção da vulnerabilidade à doença entre mulheres com diagnóstico avançado do câncer do colo do útero
Informações sobre o DOI: 10.1007/s00702-021-02447-4 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003202920.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
